Corvus Pharmaceuticals, Inc. - 10-K filing on 2022-03-10

Net Loss per Share (Tables)

12 Months Ended

Dec. 31, 2021

The following table shows the calculation of net loss per share (in thousands, except share and per share data):



	Year Ended December 31,
	2021		2020		2019
Numerator:
Net loss - basic and diluted	$	(43,241)	$	(5,995)	$	(46,672)
Denominator:
Weighted average common shares outstanding		41,854,110		29,478,878		29,364,535
Less: weighted average common shares subject to repurchase		—		—		(14,725)
Weighted average common shares outstanding used to compute basic and diluted net loss per share		41,854,110		29,478,878		29,349,810
Net loss per share, basic and diluted	$	(1.03)	$	(0.20)	$	(1.59)